According to REACH regulation, you are obliged to communicate on several issues in the supply chain and respectively in the REACH Substance Information Exchange Fora (SIEF). In SIEF communication, quite a number of information especially relating to data needs to be gathered from or fed back to co-registrants. You also need to agree on the substance Identify, the Lead registrant, on the classification and labelling, and crucial information needs to be communicated to the authorities.
ReachCentrum Communication Support helps you find out the intentions of your co-registrants, and it guarantees the best approach to contacting downstream users to gather information. It helps you store all communication and make sure information previously distributed is available, and communicate to the authorities, including ECHA and its different bodies.
Your registration is filed and you have received your registration number - you have successfully registered. However, REACH is not over yet - your dossier may be evaluated by ECHA.
Once a dossier is submitted under the registration process, it might be subject to Evaluation under REACH.
Under dossier Evaluation, European Chemicals Agency (ECHA) will evaluate all testing proposals. Of all dossiers per tonnage band 5% will undergo a compliance check by ECHA.
For substance Evaluation the Member States check if a substance can constitute a risk to human health or to the environment.
Do you have a procedure in place for this? When do you need to inform or consult the SIEF?
There are two types of evaluation: dossier evaluation and substance evaluation.
The joint submission dossier is evaluated on its content. This can be related to the testing proposals which are all checked to ensure that tests are justified and adequate to avoid unnecessary animal testing and costs. Further to this, 5% of all dossiers in a tonnage band will undergo evaluation in form of a compliance check to ensure their compliance with registration requirements. Priority is given here to dossiers with certain characteristics, e.g. dossiers submitted separately, or using a read across approach.
The submitted dossier is checked to ascertain whether the use of the substance constitutes a risk to human health or the environment.